Back to search

Article

Dynamic behavior and ligand binding properties of the wild type dCK and its characterized gemcitabine-resistant variant: a bioinformatics and computational study

2022-06-02

Abstract excerpt

In order to control the cell proliferation in various types of cancers, gemcitabine as the analogue of deoxycytidine is being used to perturb the DNA synthesis. The main challenge in using gemcitabine includes resistance of some patients to this compound due to the genetic mutations on deoxycytidine kinase (dCK) that are found in a fraction of human population. Here, we investigated the dynamics behavior and ligan...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c2bbe451-8efe-5b2e-99b0-dcb13cf44a7f
DOI
10.21203/rs.3.rs-1661054/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dynamic behavior and ligand binding properties of the wild type dCK and its characterized gemcitabine-resistant variant: a bioinformatics and computational studyDOI 10.21203/rs.3.rs-1661054/v1
Select a neighboring publication to make it the new centre.